Gerresheimer AG (GXI.DE)
EUR 53.9
(0.56%)
EUR 53.9
(0.56%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 213.39 Million EUR | 26.03% |
| 2022 | 169.31 Million EUR | 14.83% |
| 2021 | 147.44 Million EUR | -5.77% |
| 2020 | 156.46 Million EUR | 485.73% |
| 2019 | 26.71 Million EUR | -80.85% |
| 2018 | 139.45 Million EUR | -22.86% |
| 2017 | 180.79 Million EUR | 0.18% |
| 2016 | 180.46 Million EUR | -6.77% |
| 2015 | 193.57 Million EUR | 49.02% |
| 2014 | 129.89 Million EUR | -2.3% |
| 2013 | 132.94 Million EUR | 3.49% |
| 2012 | 128.46 Million EUR | 17.57% |
| 2011 | 109.26 Million EUR | 14.99% |
| 2010 | 95.02 Million EUR | 57.29% |
| 2009 | 60.41 Million EUR | -0.91% |
| 2008 | 60.97 Million EUR | 14.36% |
| 2007 | 53.31 Million EUR | 144.48% |
| 2006 | 21.8 Million EUR | 171.23% |
| 2005 | -30.61 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 31.88 Million EUR | -53.86% |
| 2024 Q2 | 59.34 Million EUR | 86.11% |
| 2024 Q3 | 48.38 Million EUR | -18.46% |
| 2023 Q3 | 53.6 Million EUR | -10.16% |
| 2023 Q4 | 69.1 Million EUR | 28.92% |
| 2023 FY | 213.39 Million EUR | 26.03% |
| 2023 Q1 | 31.01 Million EUR | -42.81% |
| 2023 Q2 | 59.66 Million EUR | 92.36% |
| 2022 Q3 | 46.27 Million EUR | -2.15% |
| 2022 Q4 | 54.23 Million EUR | 17.21% |
| 2022 FY | 169.31 Million EUR | 14.83% |
| 2022 Q2 | 47.29 Million EUR | 119.85% |
| 2022 Q1 | 21.51 Million EUR | -58.26% |
| 2021 Q2 | 42.37 Million EUR | 121.16% |
| 2021 Q4 | 51.53 Million EUR | 49.94% |
| 2021 FY | 147.44 Million EUR | -5.77% |
| 2021 Q1 | 19.16 Million EUR | -64.72% |
| 2021 Q3 | 34.37 Million EUR | -18.89% |
| 2020 Q1 | 11.86 Million EUR | 114.75% |
| 2020 FY | 156.46 Million EUR | 485.73% |
| 2020 Q4 | 54.31 Million EUR | 23.92% |
| 2020 Q3 | 43.82 Million EUR | -5.66% |
| 2020 Q2 | 46.45 Million EUR | 291.62% |
| 2019 Q4 | -80.43 Million EUR | -338.1% |
| 2019 Q3 | 33.78 Million EUR | -44.97% |
| 2019 Q2 | 61.39 Million EUR | -43.68% |
| 2019 Q1 | 109.01 Million EUR | 110.43% |
| 2019 FY | 26.71 Million EUR | -80.85% |
| 2018 Q1 | 17.31 Million EUR | -69.6% |
| 2018 FY | 139.45 Million EUR | -22.86% |
| 2018 Q3 | 33.27 Million EUR | -10.24% |
| 2018 Q2 | 37.06 Million EUR | 114.12% |
| 2018 Q4 | 51.8 Million EUR | 55.71% |
| 2017 Q1 | 28.23 Million EUR | -33.05% |
| 2017 Q3 | 46.29 Million EUR | 5.34% |
| 2017 Q4 | 56.94 Million EUR | 23.02% |
| 2017 Q2 | 43.94 Million EUR | 55.63% |
| 2017 FY | 180.79 Million EUR | 0.18% |
| 2016 Q3 | 52.04 Million EUR | -1.7% |
| 2016 Q2 | 52.94 Million EUR | 58.95% |
| 2016 Q4 | 42.17 Million EUR | -18.96% |
| 2016 FY | 180.46 Million EUR | -6.77% |
| 2016 Q1 | 33.3 Million EUR | -64.15% |
| 2015 Q4 | 92.91 Million EUR | 156.94% |
| 2015 Q1 | 24.52 Million EUR | -29.01% |
| 2015 Q3 | 36.16 Million EUR | -9.52% |
| 2015 FY | 193.57 Million EUR | 49.02% |
| 2015 Q2 | 39.97 Million EUR | 63.0% |
| 2014 Q1 | 21.67 Million EUR | -48.29% |
| 2014 FY | 129.89 Million EUR | -2.3% |
| 2014 Q4 | 34.54 Million EUR | -3.57% |
| 2014 Q3 | 35.82 Million EUR | -5.36% |
| 2014 Q2 | 37.85 Million EUR | 74.66% |
| 2013 FY | 132.94 Million EUR | 3.49% |
| 2013 Q1 | 21.47 Million EUR | -54.52% |
| 2013 Q2 | 33.6 Million EUR | 56.46% |
| 2013 Q4 | 41.91 Million EUR | 16.55% |
| 2013 Q3 | 35.95 Million EUR | 7.01% |
| 2012 Q4 | 47.22 Million EUR | 52.7% |
| 2012 Q1 | 17.39 Million EUR | -43.62% |
| 2012 FY | 128.46 Million EUR | 17.57% |
| 2012 Q2 | 32.91 Million EUR | 89.2% |
| 2012 Q3 | 30.92 Million EUR | -6.05% |
| 2011 Q2 | 30.28 Million EUR | 80.62% |
| 2011 Q1 | 16.76 Million EUR | -47.05% |
| 2011 Q3 | 31.35 Million EUR | 3.52% |
| 2011 Q4 | 30.85 Million EUR | -1.58% |
| 2011 FY | 109.26 Million EUR | 14.99% |
| 2010 Q3 | 26.31 Million EUR | 6.66% |
| 2010 Q1 | 12.16 Million EUR | -54.18% |
| 2010 Q4 | 31.66 Million EUR | 20.32% |
| 2010 Q2 | 24.67 Million EUR | 102.92% |
| 2010 FY | 95.02 Million EUR | 57.29% |
| 2009 Q2 | 11.66 Million EUR | 26.03% |
| 2009 FY | 60.41 Million EUR | -0.91% |
| 2009 Q1 | 9.25 Million EUR | 0.0% |
| 2009 Q3 | 12.87 Million EUR | 10.37% |
| 2009 Q4 | 26.53 Million EUR | 106.11% |
| 2008 FY | 60.97 Million EUR | 14.36% |
| 2007 FY | 53.31 Million EUR | 144.48% |
| 2006 FY | 21.8 Million EUR | 171.23% |
| 2005 FY | -30.61 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 192.38 Million EUR | -10.92% |
| Carl Zeiss Meditec AG | 327.13 Million EUR | 34.77% |
| Fielmann Aktiengesellschaft | 286.54 Million EUR | 25.53% |
| Sartorius Aktiengesellschaft | 543.2 Million EUR | 60.716% |
| Sartorius Aktiengesellschaft | 543.2 Million EUR | 60.716% |